DBV Technologies S.A. (DBVT) vs Puma Biotechnology, Inc. (PBYI)
- DBV Technologies S.A. DBVT 9.05 −0.66%
- Puma Biotechnology, Inc. PBYI 9.83 −6.56%
DBV Technologies S.A. and Puma Biotechnology, Inc. are both Biotechnology companies. DBV Technologies S.A. and Puma Biotechnology, Inc. are of similar size ($572.6M and $543.0M). DBV Technologies S.A. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.2×. DBV Technologies S.A. grew revenue faster over the last twelve months: 27.1% against −2.86%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs −3,564.6%) and the higher return on invested capital (42.6% vs 0.00%). Across the 17 metrics below, Puma Biotechnology, Inc. leads on 13 and DBV Technologies S.A. on 4.
Valuation
Profitability
| Metric | DBVT | PBYI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 74.83% | 65.16% |
| Operating margin | (3,601.22%) | 13.16% | 0.00% |
| Net margin | (3,564.57%) | 11.55% | 0.00% |
| Free cash flow margin | (3,456.50%) | 17.79% | 0.00% |
| Return on equity | (142.63%) | 21.97% | (56.36%) |
| Return on assets | (95.98%) | 13.78% | (48.04%) |
| Return on invested capital | 0.00% | 42.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack